Skip to main content
. 2012 Dec;78(23):8488–8491. doi: 10.1128/AEM.02258-12

Table 1.

C. coli strains employed in this study

Strain Sourcea Date (mo/yr) Antibiotic susceptibility profileb STc
6067 Water, turkey house 11/2003 TSQ 1150
6077 Turkey 12/2003 TSQ 1161
6100 Turkey 12/2003 T 1161
6252 Turkey 03/2004 TKQ 1487
6690 Turkey 05/2004 T 1833
6890 Turkey 06/2004 TQ 1161
6979 Turkey 06/2004 TKS 1150
7725 Turkey 08/2004 T 1150
8023 Turkey 08/2004 TQ 1192
8901 Turkey 10/2004 TQ 1192
WP145 Swine 12/2002 T ND
5973 Swine 10/2003 TK 1142
5974 Swine 10/2003 TSE 1151
5979 Swine 10/2003 TSK 1153
5997 Swine 11/2003 TSEK 1246
6008 Swine 11/2003 TSEK 1246
6022 Swine 11/2003 TEK 1142
6029 Swine 11/2003 TSE 1151
6084 Swine 12/2003 TE 829
6087 Swine 12/2003 TEK 828
6093 Swine 12/2003 TEK 1157
6094 Swine 12/2003 TE 1157
6123 Swine 11/2003 TEK 1164
6461 Swine 04/2004 TSE 854
a

With the exception of C. coli 6067 (isolated from water in the turkey house), bacteria were obtained as described previously (27) from fecal samples from the indicated animal source.

b

Antimicrobial susceptibility profiles were determined as described previously (10) for a panel of antibiotics, including tetracycline (T), streptomycin (S), erythromycin (E), kanamycin (K), and (fluoro)quinolones (nalidixic acid and ciprofloxacin [Q]).

c

Sequence types (STs) were determined by multilocus sequence typing as described previously (17). ND, not determined.